Published:
Biocept Awarded Accreditation by the College of American Pathologists
SAN DIEGO, Dec. 3 /PRNewswire/ -- Biocept, Inc. ("Biocept"), an emerging
leader in biotechnology, announced today their CLIA laboratory has been
awarded accreditation by the Commission on Laboratory Accreditation of the
College of American Pathologists (CAP), based on the results of a recent
on-site inspection. The laboratory's director, Philip D. Cotter, Ph.D., FACMG,
was advised of this national recognition and congratulated for the "excellence
of services being provided."
About Biocept
Biocept, an emerging biotechnology leader in cell separation technology,
is developing a new, powerful class of diagnostic assays for personalized
medicine in early detection, diagnosis and monitoring of cancer. The CEE(TM)
Cell Enrichment and Extraction platform combines sophisticated attachment
chemistry with mathematically modeled fluid dynamics and nanotechnology to
enable earlier, accurate, less invasive diagnoses. Isolation, purification and
analysis of rare cells, such as circulating tumor cells, are managed within
our state-of-the-art CLIA-accredited laboratory. The clinical laboratory is
accredited by the College of American Pathologists (CAP) and holds licenses in
California and several other states.
SOURCE Biocept, Inc.
Copyright © 2009, PRNewswire
Copyright © 2009, NewsBlaze,
Daily NewsTags: ,HEA,MTC,AWD,CA-Biocept,-Inc.
Search News
Daily News
